Star Health Share Price Target We view stocks positively and any decline in share prices offers long-term buying opportunities for investors, “said Amarjit Maurya, AVP, Research, Angel One.
Advises Star Health shareholders to consider losses at current levels; Ravi Singhal, Vice President, GCL Valuable the papers said: “Winners are advised to factor in losses at current levels as many expected the list to be weak.
The public issue was offered at a price of about 15-20% higher and, therefore, the share price of the newly listed insurance security may further decline.
Meanwhile, a Reuters report citing the company’s prospectus on Wednesday said India’s largest private health insurer Star Health will cut its initial public offering (IPO) to Rs 6,400 ($ 848.02 million) from Rs 7,249 earlier after a modest answer.
before the IPO last week. Backed by billionaire equity investor Rakesh Junjhunwala, the company has priced its IPO at between Rs 870 and 900 per share, and a bank source told Reuters the company is targeting a valuation of nearly $ 7 billion.
The weak quote came as expected after the IPO failed to attract investor interest during an initial three-day sale earlier this month.
Star Health Share Price Target 2022 , 2023 , 2024 , 2025 & 2026
Star Health and Allied Insurance Company (Star Health) debuted on the stock exchange trading its shares at Rs 845, a 6% discount from the issue price of Rs 900 per share on the National Stock Exchange (NSE).
The shares started trading at Rs 848 per share, down 5.69%, or Rs 51.2 per share, below the issue price of Rs 900 per share. A few minutes after the start of the trading day, stocks reduced their losses, and it was seen that they were climbing up, only slightly approaching the issue price.
At the end of the first day, the bond price on the BSE was Rs 906.85, 0.76% higher than the issue price, while on the NSE it was Rs 901.00, which is 0.11% higher.
More than Rs 1.34 crores (1.34,64,811) of Star Health and Allied Insurance Company shares were traded on the first day of trading on the NSE, while about 5.99 million (5.98,544) shares were traded on the BSE, data from the related stock exchange.
Star Healthcare is India’s largest retail health insurance company with a 31% market share. The company’s share in the Indian health insurance sector is 15.8%. Those who are offering shares through an offer to sell are the promoter group – Safecrop
Investments India LLP, Konark Trust, MMPL Trust – and existing investors – Apis Growth 6 Ltd, Mio IV Star, University of Notre Dame Du Lac, Mio Star, ROC Capital Pty Ltd, Venkatasami Jagannathan, Sai Satish and Burgis Minu Desai.
In the upper price range, the initial sale of the shares is expected to reach Rs 7,249.18 crore. The investment driving the IPO said they are confident that the subscription to the issue will be fully completed on the last day. The private insurer’s share offer was extended after the issue was not fully signed.
Shares reserved for Qualified Institutional Buyers (QIB) and Retail Investors are fully subscribed. There was only one mutual fund (MF) involved in the anchor segment: Edelweiss MF, which requested shares for less than Rs 15 crore.
Thereafter, the company decided to reduce the SFO to Rs 4,400 crores from Rs 5,249 earlier, and the total dropped to Rs 6,400, including a new issue of Rs 2,000.
Some investors have questioned the value of the issue as Star Health reported losses for the year ending March 2021. The company told investors last month that it will likely lose more money than they expected in fiscal 2022 after sales stop.
The drop exacerbates Peloton’s recent stock market troubles as the stock has lost more than 73% of its value since the beginning of the year due to a series of disputes, security concerns and financial constraints.
On Friday, Credit Suisse lowered its target price for the company to $ 50 from $ 112, with the analyst also downgraded the stock to neutral. The stationary bike company fell more than 5% on Friday after falling to 10% in overnight trading.
An Indian insurance company backed by billionaire Rakesh Junjhunwala and his wife Reka closed 0.8% above its IPO price of Rs 900 ($ 12) after dropping 8.1% earlier.
Star Healths’ initial public offering (IPO) of Rs 7,250 crore – the third largest this year and the eighth largest ever – has just managed to survive despite bad investor backlash with just 79% of the subscription.
On November 24, insurance company Star Health and Allied said it has set a price range of Rs 870-900 per share for its initial public offering of Rs 7.249 crore, which will open on November 30.
MUMBAI (BLOOMBERG) – Star Health and Allied Insurance will go public in Mumbai on Friday (Dec 10), the first test since Paytms debuted last month to gauge investor enthusiasm for securities offering poor prospects for short-term profitability.
Investors are increasingly skeptical of IPOs as a record year for Native American listings draws to a close.
But the restart of Sex and the City only exacerbates problems with investors, analysts say. It is overvalued at Rs 870-900 per share, despite the company incurring losses due to huge claims in the wake of the pandemic.
The company’s average retail health insurance coverage increased by an average of 11.7% from AF19 to AF21, indicating that the company is selling new policies with higher coverage.
Star Health mainly distributes its health insurance policies through individual agents, accounting for 78.9% of its total written premiums (GWP) in AF21.
As of September 30, 2021, Star Health has successfully established one of the largest health insurance hospital networks in India, with more than 11,778 hospitals.
Continue to leverage and strengthen its market leadership position-Star Health plans to use its market leadership in retail health insurance to expand its customer base while increasing profitability and leverage while benefiting from India’s favorable demographics.
No matter what health care position you are considering, the most important thing you need to check is the company’s growth prospects. Be sure to also check the stock’s price-to-earnings ratio (PEG), which includes the expected earnings growth rate (usually more than five years).
The most popular is the price-to-earnings ratio (P/E) ratio, which measures the relationship between the price of a stock and its earnings per share-the return you get for every dollar you invest.
The dividend yield shows the stock’s annual dividend payment as a percentage of the current stock price. The lower the dividend payout ratio, the more likely the company will continue to pay dividends in the future. Dividends can increase the total return you get from owning stocks.
Having determined the value of a health certificate before purchasing, it is also important to make sure that you are paying a fair price.
You can use Stockopedias stock research software to help you find the types of stocks that match your investment strategy and goals.
Investors are advised to invest after conducting appropriate analysis of the relevant companies and not blindly follow rumors, suggestions, etc.
- INR Full Form – Indian Rupee
- Dca Full Form
- Ram Full Form
- Ngo Full Form
- Usb Full Form
- Iq Full Form
- Cpu Full Form
- Pan Full Form
- Aiims Full Form
- Barc Full Form
- Gif Full Form
- Isc Full Form
- Ba Full Form
- Crpf Full Form
- Grpf Full Form
- Ntpc Full Form
- Ddc Full Form
- Physics Full Forms
- IB Full Form – Intelligence Bureau (India)
- Raw Full Form
- Ifsc Full Form
- Bts Full Form – Bangtan Boys
- Army Full Form – Alert Regular Mobility Young
- Asp Full Form – Assistant Superintendent of Police
- Dnd Full Form – Do Not Disturb
- Hiv Full Form – Human immunodeficiency virus
- Je Full Form – Junior Engineer
- Acp Full Form – Assistant Commissioners of Police
- Sdm Full Form – Subdivision Judge
- Mit Full Form – Massachusetts Institute of Technology
- Icu Full Form
- Uppsc Full Form – Uttar Pradesh Public Service Commission
- IBPS Full Form – Institute of Banking Personnel Selection
- Rrb Full Form – Railway Recruitment Board
- Llb Full Form